Cardiovascular Disease Associated with the Human Immunodeficiency Virus: An Update

Research output: Contribution to journalReview article

Abstract

With the advent of increasingly available antiretroviral therapy (ART), the life expectancy of HIV-infected persons is increasing. As they age, HIV-infected persons have increased propensity to typical diseases of aging including cardiovascular disease and accelerated atherosclerosis. The pathogenesis of HIV-associated atherosclerosis is complex and involves a state of chronic inflammation, exposure to traditional risk factors, and metabolic side effects of ART. Treatment of HIV-associated atherosclerosis should include special attention to drug-drug interactions and is best accomplished by a multidisciplinary team experienced in the care of HIV-infected persons.

Original languageEnglish (US)
Article number346
Pages (from-to)1-11
Number of pages11
JournalCurrent Treatment Options in Cardiovascular Medicine
Volume16
Issue number11
DOIs
StatePublished - Nov 1 2014

    Fingerprint

Keywords

  • Antiretroviral therapy
  • Cardiovascular disease
  • Human immunodeficiency virus
  • Prevention

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this